Amgen (AMGN) Share-based Compensation (2009 - 2026)
Amgen's Share-based Compensation came in at $165 million for Q2 2026, up 5.1% from $157 million a year earlier and up 120.0% from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) Share-based Compensation (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Amgen reported Share-based Compensation of $492 million, down 3.9% year-over-year; for FY2025, it came in at $494 million, down 6.8% from FY2024.
- Share-based Compensation carries a five-year compound annual growth rate of 8.4% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $530 million in FY2024 (+23.0%), $431 million in FY2023 (+7.5%), $401 million in FY2022 (+17.6%) and $341 million in FY2021 (+3.3%).
- The Q2 2026 figure represents the highest quarterly Share-based Compensation in data going back to Q1 2009.
- Year-over-year, Share-based Compensation increased in two of the last eight quarters, with an average decline of 2.9%.
- The fastest year-over-year change in Share-based Compensation over five years came in Q1 2024 (growth of 119.1%), and the weakest in Q1 2025 (a decline of 17.5%).
- Business Quant data shows AMGN's Share-based Compensation at $75 million (Q1 2026), $125 million (Q4 2025) and $127 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Vertex Pharmaceuticals | 135.25 Bn | 107.26 Bn | 2.84 Bn | 170.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 165.00 Mn |
| Mar 31, 2026 | 75.00 Mn |
| Dec 31, 2025 | 125.00 Mn |
| Sep 30, 2025 | 127.00 Mn |
| Jun 30, 2025 | 157.00 Mn |
| Mar 31, 2025 | 85.00 Mn |
| Dec 31, 2024 | 134.00 Mn |
| Sep 30, 2024 | 136.00 Mn |
| Jun 30, 2024 | 157.00 Mn |
| Mar 31, 2024 | 103.00 Mn |
| Dec 31, 2023 | 161.00 Mn |
| Sep 30, 2023 | 104.00 Mn |
| Jun 30, 2023 | 119.00 Mn |
| Mar 31, 2023 | 47.00 Mn |
| Dec 31, 2018 | 87.00 Mn |
| Sep 30, 2018 | 77.00 Mn |
| Jun 30, 2018 | 93.00 Mn |
| Mar 31, 2018 | 54.00 Mn |
| Dec 31, 2017 | 85.00 Mn |
| Sep 30, 2017 | 88.00 Mn |
API Access
Amgen Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();